瑞康医药

- 002589

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
瑞康医药(002589) 利润表
单位:万元
报表日期2022-09-302022-06-302022-03-312021-12-312021-09-30
一、营业总收入1,089,671.68755,107.04409,349.702,105,971.891,763,570.77
营业收入1,089,671.68755,107.04409,349.702,105,971.891,763,570.77
二、营业总成本1,073,970.73734,967.54395,574.492,055,213.181,713,842.48
营业成本906,695.28623,215.60337,957.241,722,074.231,447,631.58
营业税金及附加4,319.423,197.831,838.149,370.057,158.89
销售费用79,727.4853,723.9127,935.45174,277.86137,960.61
管理费用54,078.8434,731.1616,819.45101,988.9179,875.12
财务费用28,113.7519,378.8110,596.3646,345.8640,570.53
研发费用1,035.95720.23427.851,156.27645.74
资产减值损失----------
公允价值变动收益-10,869.27-880.90--9,351.37-6,258.72
投资收益26,114.97437.58-0.2911,483.1419,483.33
其中:对联营企业和合营企业的投资收益-------732.41--
汇兑收益----------
三、营业利润19,603.4217,208.6015,128.9649,907.5955,164.89
加:营业外收入356.81232.3565.271,054.76942.81
减:营业外支出1,517.851,031.10594.064,460.532,381.85
其中:非流动资产处置损失----------
四、利润总额18,442.3816,409.8514,600.1746,501.8253,725.85
减:所得税费用3,906.112,609.674,742.258,300.5214,782.85
五、净利润14,536.2713,800.189,857.9238,201.3038,943.00
归属于母公司所有者的净利润6,108.505,899.094,273.6613,117.8312,549.45
少数股东损益8,427.777,901.095,584.2625,083.4726,393.55
六、每股收益
基本每股收益(元/股)0.04060.03920.03000.09000.0830
稀释每股收益(元/股)0.04060.03920.03000.09000.0830
七、其他综合收益----------
八、综合收益总额14,536.2713,800.189,857.9238,201.3038,943.00
归属于母公司所有者的综合收益总额6,108.505,899.094,273.6613,117.8312,549.45
归属于少数股东的综合收益总额8,427.777,901.095,584.2625,083.4726,393.55
下载全部历史数据到excel中 返回页顶